Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

HomeCirculationVol. 148, No. 20Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Originally published13 Nov 2023https://doi.org/10.1161/CIR.0000000000001190Circulation. 2023;148:e185This article corrects the following2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesIn the article by Otto et al, “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline,” which published ahead of print on December 17, 2020, and appeared in the February 2, 2021, issue of the journal (Circulation. 2021;143:e72-e227. doi: 10.1161/CIR.0000000000000923), a correction was needed.On page e82, in Table 6, the entry for “Penicillin V potassium,” the dosage read, “200 mg orally twice daily…” It has been updated to read, “250 mg orally twice daily…”This correction has been made to the current online version of the article, which is available at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000923FootnotesCirculation is available at www.ahajournals.org/journal/circ eLetters(0) eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate. Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page. Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articles2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCatherine M. Otto, et al. Circulation. 2021;143:e72-e227 November 14, 2023Vol 148, Issue 20 Advertisement Article Information Metrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIR.0000000000001190PMID: 37956227 Originally publishedNovember 13, 2023 PDF download Advertisement